Multiple Sclerosis Trial, Recruiting (NCT04873492)

Multiple Sclerosis Trial, Recruiting NCT04873492 Sponsor: Nantes University Hospital Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT04873492 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with a "clinically isolated syndrome" (CIS) — this means you have had a first episode of neurological symptoms that may or may not suggest the early stages of MS (confirm with trial site)
You are covered by a health insurance plan
(For the "Aggressive MS" group) You started a second-level MS treatment within two years of your first episode
(For the "Non-aggressive MS" group) You either did not go on to develop full MS within 2 years of your first episode, or you did develop MS and were treated (or not treated) with a first-level MS medication within 2 years — and you have at least 2 years of medical follow-up records
(For healthy volunteers) You are 18 or older and have never had a neurological episode linked to MS or a CIS diagnosis

Who may not be able to join:

You are currently taking part in another clinical study
You are not willing to have your genetic information analysed
You are currently taking medication that suppresses your immune system
You have had a plasma exchange treatment or taken corticosteroids (anti-inflammatory steroids) within the past four weeks before giving a blood sample
You are under a legal protection arrangement, such as guardianship or trusteeship (confirm with trial site)
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33 2 40 16 52 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04873492

Sponsor: Nantes University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 33 2 40 16 52 00

More information: https://clinicaltrials.gov/study/NCT04873492

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with a "clinically isolated syndrome" (CIS) — this means you have had a first episode of neurological symptoms that may or may not suggest the early stages of MS (confirm with trial site)
You are covered by a health insurance plan
(For the "Aggressive MS" group) You started a second-level MS treatment within two years of your first episode
(For the "Non-aggressive MS" group) You either did not go on to develop full MS within 2 years of your first episode, or you did develop MS and were treated (or not treated) with a first-level MS medication within 2 years — and you have at least 2 years of medical follow-up records
(For healthy volunteers) You are 18 or older and have never had a neurological episode linked to MS or a CIS diagnosis

Who may not be able to join:

You are currently taking part in another clinical study
You are not willing to have your genetic information analysed
You are currently taking medication that suppresses your immune system
You have had a plasma exchange treatment or taken corticosteroids (anti-inflammatory steroids) within the past four weeks before giving a blood sample
You are under a legal protection arrangement, such as guardianship or trusteeship (confirm with trial site)
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nantes University Hospital

Registry

ClinicalTrials.gov

Start date

24 January 2022

Est. completion

24 July 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Bulk RNA-sequencing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov